Advertisement

Genetic Testing Not Offered Enough to Breast Cancer Patients

Only a relatively small proportion of women with early-stage breast cancer receive genetic testing prior to surgery, despite the fact that the majority of such women would like to be tested, and many women would stand to benefit from knowing their mutation carrier status, a large, population-based study concludes.

 MedscapeNews

click me